Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: highlighting their potential for transdiagnostic therapeutics

C Driver, TNW Jackson, J Lagopoulos… - Progress in Neuro …, 2022 - Elsevier
The so-called “psychedelic renaissance” has stimulated expanded interest in several
classes of drugs that appear to possess transdiagnostic effects in the treatment of mental …

New treatment strategies of depression: based on mechanisms related to neuroplasticity

YJ Huang, HY Lane, CH Lin - Neural plasticity, 2017 - Wiley Online Library
Major depressive disorder is a severe and complex mental disorder. Impaired
neurotransmission and disrupted signalling pathways may influence neuroplasticity, which …

Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression

E Malatynska, HWM Steinbusch, O Redkozubova… - Experimental …, 2012 - Elsevier
The prevalence of depression increases with aging. We hypothesized that like humans, old
animals exhibit anhedonic-like behavior, along with signs of behavioral despair. In rodents …

mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants

S Chaki, Y Ago, A Palucha-Paniewiera, F Matrisciano… - …, 2013 - Elsevier
Major depressive disorder is among the most prevalent forms of mental illness. All currently
available antidepressant medications have stemmed from study of the mechanisms of …

Roles of glutamate signaling in preclinical and/or mechanistic models of depression

K Tokita, T Yamaji, K Hashimoto - Pharmacology Biochemistry and …, 2012 - Elsevier
Accumulating evidence suggests that the glutamatergic system plays important roles in the
pathophysiology and treatment of major depressive disorder (MDD). Abnormalities in the …

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research

C Fabbri, G Di Girolamo… - American Journal of …, 2013 - Wiley Online Library
Major depressive disorder (MDD) is an emergent cause of personal and socio‐economic
burden, both for the high prevalence of the disorder and the unsatisfying response rate of …

Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action

H Zhong, N Haddjeri, C Sánchez - Psychopharmacology, 2012 - Springer
Rationale Escitalopram is a widely used antidepressant for the treatment of patients with
major depression. It is the pure S-enantiomer of racemic citalopram. Several clinical trials …

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression

G Salvadore, JW van der Veen, Y Zhang… - International Journal …, 2012 - academic.oup.com
Amino-acid neurotransmitter system dysfunction plays a major role in the pathophysiology of
major depressive disorder (MDD). We used proton magnetic resonance spectroscopy (1H …

α-Actinin anchors PSD-95 at postsynaptic sites

L Matt, K Kim, AC Hergarden, T Patriarchi, ZA Malik… - Neuron, 2018 - cell.com
Despite the central role PSD-95 plays in anchoring postsynaptic AMPARs, how PSD-95
itself is tethered to postsynaptic sites is not well understood. Here we show that the F-actin …

Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy

PR Albert, B Le François - Frontiers in neuroscience, 2010 - frontiersin.org
Major depression is the most common form of mental illness, and is treated with
antidepressant compounds that increase serotonin (5-HT) neurotransmission. Increased 5 …